Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Cascadia Behavioral Healthcare
LifeWorks Northwest
Oregon Health and Science University
University of Medicine and Dentistry New Jersey
Information provided by (Responsible Party):
Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT00866372
First received: March 19, 2009
Last updated: February 28, 2012
Last verified: February 2012

March 19, 2009
February 28, 2012
October 2009
March 2013   (final data collection date for primary outcome measure)
reducing weight and BMI [ Time Frame: Baseline, 6-, 12-, and 24-months ] [ Designated as safety issue: No ]
reducing weight and BMI [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00866372 on ClinicalTrials.gov Archive Site
 
 
 
 
 
Reducing Weight and Diabetes Risk in an Underserved Population
Reducing Weight and Diabetes Risk in an Underserved Population

This study will examine whether a lifestyle change program to reduce weight and diabetes risk factors will be effective among people with serious mental illnesses. If the results are positive, it could help people with mental illness improve their health and reduce their diabetes risk.

 
Interventional
 
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Investigator, Outcomes Assessor)
Primary Purpose: Prevention
  • Diabetes Mellitus
  • Overweight
Behavioral: Life style Intervention
Translational randomized controlled trial assessing the effectiveness of a known efficacious and comprehensive lifestyle intervention in an underserved mentally ill population at high risk for obesity and diabetes.
 
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
280
March 2013
March 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • age ≥18
  • taking antipsychotic agents
  • overweight or obese (BMI of 25-44.9)

Exclusion Criteria:

  • diagnoses of dementia
  • serious illnesses,including cancer or bariatric surgery history
  • women who are pregnant, breastfeeding, or plan a pregnancy during the study
  • recent (prior 30 days) mental health hospitalizations
  • enrollment in another weight reduction program
  • those planning to move outside the area before the trial is complete (to prevent attrition)
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00866372
R18 DK76775, R18DK076775
Yes
Kaiser Permanente
Kaiser Permanente
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Cascadia Behavioral Healthcare
  • LifeWorks Northwest
  • Oregon Health and Science University
  • University of Medicine and Dentistry New Jersey
Principal Investigator: Carla A Green, PhD, MPH Kaiser Permanente
Kaiser Permanente
February 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP